Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Solid Tumor Cancer × Paclitaxel × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 12 Carcinoma, Non-Small-Cell Lung 5 Ovarian Neoplasms 4 Uterine Cervical Neoplasms 3 Stomach Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Triple Negative Breast Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Thrombosis 1 Stage IA Uterine Sarcoma 1 Solid Tumors 1 Solid Tumor Cancer 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Peripheral Nervous System Diseases 1 Pancreatic Intraductal Neoplasms 1 Pancreatic Cyst 1 Pain 1 Organoid 1 Neoplasms, Germ Cell and Embryonal 1 NSCLC 1 Medulloblastoma 1 Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer 1 Infections 1 Hepatoblastoma 1

Interventions

TP protocol 1 Pemetrexed 1 Paclitaxel 1 PE regimen 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06649448 2024-10-18

EF-001

Shandong Cancer Hospital and Institute

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡